El Vínculo El Vínculo.
Caraş-Severin
Awarded European Union SuppliesFramework agreement

ACORD CADRU furnizare medicamente PROGRAME NATIONALE

Buyer: SPITALUL JUDETEAN RESITA

Awarded to MEDIPLUS EXIM and 3 others. Estimated value: 21,401,294 RON.

21,401,294 RON
Estimated value
32
Lots
3
Bids received

Description

Obiectul procedurii de achiziţie publica îl constituie achizitia de medicamente P.N.ONCOLOGIE si PN HIV– conform solicitarii Sectiille oncologie si HIV din cadrul SJUR. Aceste produse sunt necesare pentru desfasurarea in bune conditii a activitatii medicale specifice Spitalului Judetean de Urgenta. Medicamentele au fost cuprinse in proceduri de licitatie anterioare dar fie au fost anulate in cadrul acestora, fie nu au fost prezentate oferte pentru acestea.

Lots (32)

LotDescriptionCPV codeAmount
1 Atezolizumab - 1200mg/ 20ml - conc pt sol perf - flacon
RO422
33652100 Antineoplastic agents 2,325,331 RON
2 Atezolizumab - 840mg/ 14ml - conc pt sol perf - flacon
RO422
33652100 Antineoplastic agents 1,604,241 RON
3 Avelumabum - 20mg/ ml - conc pt sol perf - flacon 10 ml (200 mg avelumab)
RO422
33652100 Antineoplastic agents 1,161,516 RON
4 Bleomycinum sulfas - 15mg (15000UI) - pulb.pt.sol. Inj - flacon 6ml
RO422
33652100 Antineoplastic agents 8,416 RON
5 Cisplatinum - 1mg/ml - conc pt sol perf - flacon 50 ml
RO422
33652100 Antineoplastic agents 13,068 RON
6 Cisplatinum - 1mg/ml - conc.pt.sol.perf. - flacon10 ml
RO422
33652100 Antineoplastic agents 5,832 RON
7 Cyclophosphamidum - 1000mg/ 2ml - conc.pt.sol. perf. / inj - flacon 2 ml
RO422
33652100 Antineoplastic agents 237,600 RON
8 Cyclophosphamidum - 500mg/ml - conc.pt.sol. perf. / inj - flacon2 ml
RO422
33652100 Antineoplastic agents 241,920 RON
9 Cyclophosphamidum - 2000mg/ 4ml - conc.pt.sol. perf. / inj - flacon 5 ml
RO422
33652100 Antineoplastic agents 142,560 RON
10 Doxorubicinum - 2mg/ml- conc.pt.sol. perf. - flacon a 5 ml continand 10 mg doxorubicina
RO422
33652100 Antineoplastic agents 4,262 RON
11 Doxorubicinum - 2mg/ml - conc.pt.sol. perf. - flacon a 25 ml continand 50 mg doxorubicina
RO422
33652100 Antineoplastic agents 92,995 RON
12 Doxorubicinum - 2mg/ml- conc.pt.sol. perf. - flacon a 50 ml continand 100 mg doxorubicina
RO422
33652100 Antineoplastic agents 399,030 RON
13 Durvalumabum - 50mg/ml - conc.pt.sol. perf. - flacon 10 ml (contine 500mg durvalumab)
RO422
33652100 Antineoplastic agents 3,299,623 RON
14 Epirubicinum - 2mg/ml- sol inj./perf - flacon 10 ml sol. inj. x 20mg (20mg/10ml)
RO422
33652100 Antineoplastic agents 33,314 RON
15 Ipilimumabum - 5mg/ml - conc.pt.sol. perf. - flacon x 10 ml concentrat (50mg ipilimumab)
RO422
33652100 Antineoplastic agents 1,842,621 RON
16 Ipilimumabum- 5mg/ml - conc.pt sol perf - flacon x 40 ml concentrat (200mg ipilimumab)
RO422
33652100 Antineoplastic agents 1,839,381 RON
17 Irinotecanum - 4,3mg/ml - conc pt dispersie perf. - flacon 10ml
RO422
33652100 Antineoplastic agents 710,901 RON
18 Panitumumabum- 20mg/ml - conc.pt sol perf - flacon x 100mg panitumumab x 5ml
RO422
33652100 Antineoplastic agents 237,341 RON
19 Panitumumabum - 20mg/ml- conc.pt sol perf- flacon x 400mg panitumumab x 20ml
RO422
33652100 Antineoplastic agents 933,161 RON
20 Pembrolizumabum- 25mg/ml - conc.pt sol perf - flacon 4 ml
RO422
33652100 Antineoplastic agents 2,902,052 RON
21 Pertuzumabum - 420mg- conc.pt sol perf- flacon 14 ml
RO422
33652100 Antineoplastic agents 1,829,725 RON
22 Ramucirumabum- 10mg/ml - conc.pt sol perf - flacon 10 ml
RO422
33652100 Antineoplastic agents 150,622 RON
23 Topotecanum - 1mg/ml- conc.pt sol perf- flacon 5ml continand 4 mg topotecan
RO422
33652100 Antineoplastic agents 68,335 RON
24 Trastuzumabum emtansinum- 100mg- pulb.pt conc pt sol perf- flacon 15ml
RO422
33652100 Antineoplastic agents 1,183,300 RON
25 Bendamustinum - 2,5mg/ml- pulb.pt conc pt sol perf - flacon 50 ml (contine 100 mg bendamustina)
RO422
33652100 Antineoplastic agents 43,435 RON
26 Bendamustinum- 2,5mg/ml- pulb.pt conc pt sol perf- flacon 20 ml (contine 25 mg bendamustina)
RO422
33652100 Antineoplastic agents 40,433 RON
27 Bendamustinum - 2,5mg/ml- pulb.pt conc pt sol perf - flacon 10 ml (contine 25 mg bendamustina)
RO422
33652100 Antineoplastic agents 13,485 RON
28 Bendamustinum- 25mg/ml- pulb.pt conc pt sol perf- flac. din sticlă brună introduse într-un plic protector cu 4 ml conc. pt. sol. perf.
RO422
33652100 Antineoplastic agents 19,202 RON
29 Zidovudinum - 10mg/ml- sol.orala- flacon 200 ml
RO422
33651400 Antivirals for systemic use 1,742 RON
30 Abacavirum - 300mg - compr. film
RO422
33651400 Antivirals for systemic use 821 RON

Award criteria

  • Price — Pretul cel mai scazut este singurul criteriu

Awards

Awarded toAmountDate
MEDIPLUS EXIM 3,299,623 RON 21 June 2023
ALLIANCE HEALTHCARE ROMÂNIA SRL 2,901,939 RON 30 June 2023
MEDIPLUS EXIM 2,857,042 RON 30 June 2023
ALLIANCE HEALTHCARE ROMÂNIA SRL 2,325,331 RON 30 June 2023
DONA. LOGISTICA 2,325,305 RON 30 June 2023
MEDIPLUS EXIM 2,313,884 RON 30 June 2023
MEDIPLUS EXIM 1,842,621 RON 30 June 2023
ALLIANCE HEALTHCARE ROMÂNIA SRL 1,842,585 RON 30 June 2023
ALLIANCE HEALTHCARE ROMÂNIA SRL 1,839,326 RON 30 June 2023
DONA. LOGISTICA 1,829,725 RON 30 June 2023

Official publications

  • TED · 00711966-2026 · 15 October 2026
  • OJS · 200/2026 · 15 October 2026

Other tenders from SPITALUL JUDETEAN RESITA

Frequently asked questions

What is the estimated value of this tender?
The estimated value published by the buyer is 21,401,294 RON.
Who is the buyer of this tender?
The contracting authority is SPITALUL JUDETEAN RESITA (European Union).
How can I bid for public tenders in the European Union?
Bids are submitted through the official public procurement portal in the European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new public tenders published in the European Union that match your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.